Hydrosyringomyelia in demyelinating diseases

被引:0
|
作者
Gatto, EM
Reisin, R
Nogués, M
Roca, MCU
Domínguez, R
Giannaula, R
Zurrú, MC
Rugilo, C
机构
[1] Dept Neurol, Buenos Aires, DF, Argentina
[2] Sanatorio Mitre, Buenos Aires, DF, Argentina
[3] FLENI, Buenos Aires, DF, Argentina
[4] Hosp Britanico, Buenos Aires, DF, Argentina
[5] Hosp Sirio Libanes, Buenos Aires, DF, Argentina
[6] Hosp Espanol, Buenos Aires, DF, Argentina
来源
NEUROLOGIA | 2002年 / 17卷 / 03期
关键词
hydrosyringamyelia; Devic's syndrome; multiple sclerosis; syringomyelia;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal cord cavitation is a frequent finding in optic neuromyelitis (Devic's syndrome) (DS) but it is also, although rarely, observed in patients with multiple sclerosis (MS). The objective of our study was to compare the MRI characteristics of the syringomyelic cavities in 6 patients with DS and 3 patients with MS. All the patients with DS had a relapsing clinical form with normal brain MRI. Spinal MRI revealed unenhanced central cavities which extended more than 3 vertebral bodies and remained unchanged in follow-up studies. Two patients presented multiple cavities. MS patients suffered a relapsing remitting form of the disease, they all had hyperintense T2 enhancing lesions on their spinal MRI. Moreover spinal MRI also revealed non communicating cavities which extended less than 2 vertebral bodies. Follow-up studies in MS patients revealed a reduction of both the spinal lesions and the cavities. It is still debated whether DS represents a distinct clinical entity different from MS. These findings help distinguishing both disorders in cases when spinal cavities are present and also contribute to the therapeutic choice.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 50 条
  • [41] IMMUNOLOGICAL ASPECTS ON DEMYELINATING DISEASES
    NILSSON, O
    ACTA NEUROLOGICA SCANDINAVICA, 1972, 48 : 321 - +
  • [42] OPHTHALMIC ASPECTS OF DEMYELINATING DISEASES
    SCOTT, GI
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1961, 54 (01): : 38 - 42
  • [43] Role of interferons in demyelinating diseases
    Arnason, BGW
    Toscas, A
    Dayal, A
    Qu, Z
    Noronha, A
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1997, (49): : 117 - 123
  • [44] HEREDITARY DEMYELINATING DISEASES, LEUCODYSTROPHIES
    FRANCOIS, J
    JOURNAL DE GENETIQUE HUMAINE, 1979, 27 (02): : 123 - 130
  • [45] Peripheral Inflammation and Demyelinating Diseases
    Murta, Veronica
    Ferrari, Carina
    GLIAL CELLS IN HEALTH AND DISEASE OF THE CNS, 2016, 949 : 263 - 285
  • [46] HUMAN RETROVIRUSES AND DEMYELINATING DISEASES
    GREENBERG, SJ
    NEUROLOGIC CLINICS, 1995, 13 (01) : 75 - 97
  • [47] Movement disorders in demyelinating diseases
    Candeias da Silva, C.
    Bichuetti, D. B.
    Azevedo Silva, S. M.
    Ferraz, H. B.
    Oliveira, E. M. L.
    Borges, V.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 163 - 163
  • [48] DEMYELINATING AND NEOPLASTIC DISEASES IN PREGNANCY
    WEINREB, HJ
    NEUROLOGIC CLINICS, 1994, 12 (03) : 509 - 526
  • [49] DEMYELINATING, INFLAMMATORY AND DEGENERATIVE DISEASES
    MILLER, DH
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1990, 3 (06): : 881 - 883
  • [50] IMMUNOLOGICAL ASPECTS OF DEMYELINATING DISEASES
    MARTIN, R
    MCFARLAND, HF
    MCFARLIN, DE
    ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 : 153 - 187